Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 2-3, 2010, Pages 111-119

  Conklin, Sarah M ^a,b   Runyan, Caroline A ^c   Leonard, Sherry ^a   Reddy, Ravinder D ^a,d   Muldoon, Matthew F ^a,e   Yao, Jeffrey K ^a,d,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ALLEGHENY COLLEGE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Age; Anterior cingulate cortex; Arachidonic acid; Depression; Docosahexaenoic acid; Eicosapentaenoic acid; N 3 fatty acids; N 6 fatty acids; Postmortem

Indexed keywords

BIOLOGICAL MARKER; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN REGION; CAPILLARY GAS CHROMATOGRAPHY; CINGULATE GYRUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID DESATURATION; FEMALE; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MAJOR DEPRESSION; MALE; NEUROIMAGING; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS;

ADULT; AGE FACTORS; AGED; BRAIN; CHROMATOGRAPHY, GAS; DEPRESSIVE DISORDER, MAJOR; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 77951626613     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.12.002     Document Type: Article

References (57)

1. Freeman M.P., Hibbeln J.R., Wisner K.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 2006, 67:1954-1967.
2. Kitajka K., Sinclair A.J., Weisinger R.S., Weisinger H.S., Mathai M., Jayasooriya A.P., Halver J.E. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc. Natl. Acad. Sci 2004, 101:10931-10936.
3. Hulbert A.J., Turner N., Storlien L.H., Else P.L. Dietary fats and membrane function: implications for metabolism and disease. Biol. Rev. 2005, 80:155-169.
4. Tashiro T., Yamamori H., Takagi K., Hayashi N., Furukawa K., Nakajima N. N-3 Versus N-6 polyunsaturated fatty acids in critical illness. Nutrition 1998, 14:551-553.
5. Young G., Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod. Nutr. Dev. 2005, 45:1-28.
6. Hibbeln J.R. Fish consumption and major depression. Lancet 1998, 351:1213.
7. Hibbeln J.R. Seafood consumption, the DHA content of mothers milk and prevalence rates of postpartum depression: a cross-national. ecological analysis. J. Affect. Disord 2002, 69:15-29.
8. Tanskanen A., Hibblen J.R., Tuomilehto J., Uutela A., Haukala A., Viinamaki H., Lehtonen J. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr. Serv. 2001, 52:529-531.
9. Peet M., Murphy B., Shay J., Horrobin D.F. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 1998, 43:315-319.
10. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., Meltzer H.Y. Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased c20:4ω6/c20:5ω3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 1996, 38:35-46.
11. Chui C.C., Huang S.Y., Su K.P., Lu M.L., Huang M.C., Chen C.C., Shen W.W. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur. Neurophyschopharma. 2003, 13:99-103.
12. Stoll A.L., Severus W.E., Freeman M.P. Omega-3 fatty acids in bipolar disorder: a preliminary double blind, placebo-controlled trial. Arch. Gen. Psychiatry 1999, 56:407-412.
13. Zanarini M.C., Frakenburg F.R. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am. J. Psychiatry 2003, 160:167-169.
14. Frasure-Smith N., Lesperance F., Julien P. Major depression is associated with lower omega-3 fatty acids levels in patients with recent acute coronary syndromes. Biol. Psychiatry 2004, 55:891-896.
15. Nemets B., Stahl Z., Belmaker R.H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am. J. Psychiatry 2002, 159:477-479.
16. Peet M., Horrobin D.F. A dose-ranging study of the effects of ethyl-eicopentaenoic acid in patients with on-going depression in spite of apparently adequate treatment with standard drugs. Arch. Gen. Psychiatry 2001, 59:913-919.
17. Su K.P., Huang S.Y., Chiu C.C. Omega-3 fatty acids in major depressive disorder: a preliminary double-blind placebo controlled trial. Eur. Neuropsychopharm. 2003, 13:267-271.
18. Marangell L.B., Martinez J.M., Zboyan H.A., et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry 2003, 160:996-998.
19. Ness A.R., Gallacher J.E., Bennett P.D., Gunnell D.J., Rogers P.J., Kessler D., Burr M.L. Advice to eat fish and mood: a randomized controlled trial of men with angina. Nutritional Neuroscience 2003, 6:63-65.
20. Rogers P.J., Appleton K.M., Kesler D., Peters T.J., Gunnell D., Hayward R.C., Heatherley S.V., Christian L.M., McNaughton S.A., Ness A.R. No effect of n-3 long-chain polyunsaturated fatty acids (EPA and DHA) supplementation on depressed mood and cognitive function: a randomized controlled trial. Br. J. Nutr. 2008, 99:421-431.
21. Conklin S.M., Harris J.I., Manuck S.B., Yao J.K., Hibbeln J.R., Muldoon M.F. Serum ω-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res. 2007, 152:1-10.
22. Lalovic A., Levy E., Canetti L., Sequeira A., Montoudis A., Turecki G. Fatty acid composition in postmortem brains of people who completed suicide. J. Psychiatry Neurosci. 2007, 32:363-370.
23. McNamara R.K., Hahn C.H., Jandacek R., Rider T., Tso P., Stanford K.E., Richtand N.M. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol. Psychiatry 2007, 62:17-24.
24. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K.E., Hahn C.G., Richtand N.M. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res. 2008, 160:285-299.
25. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog. Brain Res. 2000, 413-431.
26. Van Veen V., Cohen J.D., Botvinick M.M., Stenger V., Carter C.S. Anterior cingulate cortex, conflict monitoring and levels of processing. NeuroImage 2001, 14:1302-1308.
27. MacDonald A.W., Cohen J.D., Stenger V.A., Carter C.S. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000, 288:1835-1838.
28. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann. NY Acad. Sci. 1999, 877:614-637.
29. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., Kendrick A.D., Davis T.L., Jiang A., Cohen M.S., Stern C.E., Belliveau J.W., Baer L., O'Sullivan R.L., Savage C.R., Jenike M.A., Rosen B.R. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch. Gen. Psychiatry 1996, 53:595-606.
30. Amir N., Klumpp H., Elias J., Bedwell J.S., Yanasak N., Miller L.S. Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia. Biol. Psychiatry 2005, 57:975-981.
31. Binder D.K., Iskandar B.J. Modern neurosurgery for psychiatric disorders. Neurosurgery 2000, 47:9-21.
32. Gianaros P.J., Derbyshire S.W.G., May C., Siegle G.J., Gamalo M.A., Jennings J.R. Anterior cingulate activity correlates with blood pressure during stress. Psychophysiology 2005, 42:627-635.
33. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatry Clin. Neurosci. 1997, 9:471-481.
34. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercromnie H.C., Schaefew S.M., Koger J.V., Benca R.M., Davidson R. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am. J. Psychiatry 2001, 158:405-415.
35. Parker G., Gibson N.A., Brotchie H., Heruc G., Rees A.M., Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 2006, 163:969-978.
36. Conklin S.M., Gianaros P.J., Brown S.M., Yao J.K., Hariri A.R., Manuck S.B., Muldoon M.F. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 2007, 421:209-212.
37. Leonard S., Logel J., Luthman D., Casanova M., Kirch D., Freedman R. Biological stability of MRNA isolated from human postmortem brain collection. Biol. Psychiatry 1993, 33:456-466.
38. Hardy J.A., Wester P., Winblad B., Gezelius C., Bring G., Eriksson A. The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J. Neural Transm. 1985, 61:253-264.
39. Yao J.K., van Kammen D.P., Welker J.A. Red blood cell membrane dynamics in schizophrenia. II. fatty acid composition. Schizophr. Res. 1994, 13:217-226.
40. Yao J.K., Leonard S., Reddy R. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr. Res. 2000, 42:7-17.
41. Elliott K.A.C., Jasper H. Measurement of experimentally induced brain swelling and shrinkage. Am. J. Physiol. 1949, 157:122-129.
42. Carver J.D., Benford V.J., Han B., Cantor A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 2001, 56:79-85.
43. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. Alpha-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 1996, 66:1582-1591.
44. De la Pressa Owens S., Innis S.M. Docosahexaenoic and arachidonic Acid prevent a decrease in dopoaminergic and serotonergic neurotransmitters in frontal cortex caused by linoleic and alpha-linoleic acid deficient diet in formula-fed piglets. J. Nutr. 1999, 129:2088-2093.
45. Kodas E., Vancassel S., Lejeune B., Guilloteau D., Chalon S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J. Lipid Res. 2002, 43:1209-1219.
46. McNamara R.K., Ostrander M., Abplanalp W., Richtand N.M., Benoit S.C., Clegg D.J. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:237-257.
47. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., Durand G., Chalon S. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am. J. Clin. Nutr. 2002, 75:662-667.
48. DeMar J.C., Ma K., Bell J.M., Igarashi M., Greenstein D., Rapoport S.I. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 2006, 47:172-180.
49. Calderon F., Kim H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 2004, 90:979-988.
50. Kawakita E., Hashimoto M., Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 139:991-997.
51. Song C., Manku M.S., Horrobin D.F. Long-chain polyunsaturated fatty acids modulate interleukin-1 beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. J. Nutr. 2008, 138:954-963.
52. Malerba G., Schaeffer I., Xumerle L., Klopp N., Trabetti E., Biscuola M., Cavallari U., Galavotti R., Martinelli N., Guarini P., Girelli D., Olivieri O., Corrocher R., Heinrich J., Pignatti P.F., Illig T. SNPs of the FADS gene clusters are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008, 43:289-299.
53. Koletzko B., Demmelmair H., Schaeffer L., Illig T., Heinrich J. Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements. Nestle Nutr. Workshop Ser. Pediatr. Program 2008, 62:35-49.
54. R. Pawlosky, J. Hibbeln, B. Wegher, N. Sebring, N. Salem Jr, The effects of cigarette smoking on the metabolism of essential fatty acids, Lipids (1999) 34 Suppl S287.
55. Hibbeln J.R., Makino K.K., Martin C.E., Dickerson F., Boronow J., Fenton W.S. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol. Psychiatry 2003, 53:431-441.
56. Sublette M., Milak M.S., Hibbeln J.R., Freed P.J., Oquendo M.A., Malone K.M., Parsey R.V., Mann J.J. Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:57-64.
57. Edwards R., Peet M., Shay J., Horrobin D.F. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect Disord. 1998, 48:149-155.